199 related articles for article (PubMed ID: 24058450)
1. Immunization against GAD induces antibody binding to GAD-independent antigens and brainstem GABAergic neuronal loss.
Chang T; Alexopoulos H; Pettingill P; McMenamin M; Deacon R; Erdelyi F; Szabó G; Buckley CJ; Vincent A
PLoS One; 2013; 8(9):e72921. PubMed ID: 24058450
[TBL] [Abstract][Full Text] [Related]
2. Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome.
Chang T; Alexopoulos H; McMenamin M; Carvajal-González A; Alexander SK; Deacon R; Erdelyi F; Szabó G; Lang B; Blaes F; Brown P; Vincent A
JAMA Neurol; 2013 Sep; 70(9):1140-9. PubMed ID: 23877118
[TBL] [Abstract][Full Text] [Related]
3. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies.
Ali F; Rowley M; Jayakrishnan B; Teuber S; Gershwin ME; Mackay IR
J Autoimmun; 2011 Sep; 37(2):79-87. PubMed ID: 21680149
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity.
Gresa-Arribas N; Ariño H; Martínez-Hernández E; Petit-Pedrol M; Sabater L; Saiz A; Dalmau J; Graus F
PLoS One; 2015; 10(3):e0121364. PubMed ID: 25774787
[TBL] [Abstract][Full Text] [Related]
5. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies.
Dalakas MC; Li M; Fujii M; Jacobowitz DM
Neurology; 2001 Sep; 57(5):780-4. PubMed ID: 11552003
[TBL] [Abstract][Full Text] [Related]
6. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.
Dinkel K; Meinck HM; Jury KM; Karges W; Richter W
Ann Neurol; 1998 Aug; 44(2):194-201. PubMed ID: 9708541
[TBL] [Abstract][Full Text] [Related]
8. Neurological Syndromes Associated with Anti-GAD Antibodies.
Dade M; Berzero G; Izquierdo C; Giry M; Benazra M; Delattre JY; Psimaras D; Alentorn A
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456344
[TBL] [Abstract][Full Text] [Related]
9. Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome.
Rizzi M; Knoth R; Hampe CS; Lorenz P; Gougeon ML; Lemercier B; Venhoff N; Ferrera F; Salzer U; Thiesen HJ; Peter HH; Walker UA; Eibel H
PLoS One; 2010 May; 5(5):e10838. PubMed ID: 20520773
[TBL] [Abstract][Full Text] [Related]
10. Identification of autoantibody epitopes of glutamic acid decarboxylase in stiff-man syndrome patients.
Li L; Hagopian WA; Brashear HR; Daniels T; Lernmark A
J Immunol; 1994 Jan; 152(2):930-4. PubMed ID: 7506741
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.
Martinez-Hernandez E; Ariño H; McKeon A; Iizuka T; Titulaer MJ; Simabukuro MM; Lancaster E; Petit-Pedrol M; Planagumà J; Blanco Y; Harvey RJ; Saiz A; Graus F; Dalmau J
JAMA Neurol; 2016 Jun; 73(6):714-20. PubMed ID: 27065452
[TBL] [Abstract][Full Text] [Related]
12. Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome.
Raju R; Rakocevic G; Chen Z; Hoehn G; Semino-Mora C; Shi W; Olsen R; Dalakas MC
Brain; 2006 Dec; 129(Pt 12):3270-6. PubMed ID: 16984900
[TBL] [Abstract][Full Text] [Related]
13. The neurological syndromes associated with glutamic acid decarboxylase antibodies.
Baizabal-Carvallo JF
J Autoimmun; 2019 Jul; 101():35-47. PubMed ID: 31000408
[TBL] [Abstract][Full Text] [Related]
14. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome.
Butler MH; Solimena M; Dirkx R; Hayday A; De Camilli P
J Exp Med; 1993 Dec; 178(6):2097-106. PubMed ID: 8245784
[TBL] [Abstract][Full Text] [Related]
15. [Stiff-Person Syndrome and Related Autoantibodies].
Matsui N; Tanaka K; Kaji R
Brain Nerve; 2018 Apr; 70(4):357-362. PubMed ID: 29632283
[TBL] [Abstract][Full Text] [Related]
16. Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats.
Hansen N; Grünewald B; Weishaupt A; Colaço MN; Toyka KV; Sommer C; Geis C
Exp Neurol; 2013 Jan; 239():202-9. PubMed ID: 23099416
[TBL] [Abstract][Full Text] [Related]
17. Stiff Person syndrome and other anti-GAD-associated neurologic disorders.
Dayalu P; Teener JW
Semin Neurol; 2012 Nov; 32(5):544-9. PubMed ID: 23677666
[TBL] [Abstract][Full Text] [Related]
18. Anti-GAD Antibodies and the Cerebellum: Where Do We Stand?
Manto M; Mitoma H; Hampe CS
Cerebellum; 2019 Apr; 18(2):153-156. PubMed ID: 30343467
[TBL] [Abstract][Full Text] [Related]
19. [Stiff-person syndrome and related autoantibodies].
Tomioka R; Tanaka K
Brain Nerve; 2013 Apr; 65(4):395-400. PubMed ID: 23568987
[TBL] [Abstract][Full Text] [Related]
20. Characterization of CD4+ T cells specific for glutamic acid decarboxylase (GAD65) and proinsulin in a patient with stiff-person syndrome but without type 1 diabetes.
Hänninen A; Soilu-Hänninen M; Hampe CS; Deptula A; Geubtner K; Ilonen J; Knip M; Reijonen H
Diabetes Metab Res Rev; 2010 May; 26(4):271-9. PubMed ID: 20503259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
